Anzeige
Mehr »
Freitag, 06.06.2025 - Börsentäglich über 12.000 News
Starke Zahlen: EBITDA bei 9 Mio.?€ - Startet jetzt die Neubewertung?
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A40CR1 | ISIN: US42254E3027 | Ticker-Symbol:
NASDAQ
05.06.25 | 21:58
3,560 US-Dollar
0,00 % 0,000
Branche
Gesundheitswesen
Aktienmarkt
Sonstige
1-Jahres-Chart
HEARTSCIENCES INC Chart 1 Jahr
5-Tage-Chart
HEARTSCIENCES INC 5-Tage-Chart

Aktuelle News zur HEARTSCIENCES Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
MiHeartSciences: FDA Grants Breakthrough Device Designation For Aortic Stenosis ECG Algorithm-
HEARTSCIENCES Aktie jetzt für 0€ handeln
MiHeartSciences Inc.: HeartSciences Receives FDA Breakthrough Device Designation for MyoVista Insights AI-ECG Algorithm for Detecting Aortic Stenosis113Southlake, TX, June 04, 2025 (GLOBE NEWSWIRE) -- HeartSciences Inc. (Nasdaq: HSCS; HSCSW) ("HeartSciences" or the "Company"), an artificial intelligence ("AI") powered medical technology company focused...
► Artikel lesen
DiHeartSciences Inc.: Foundational US Patent Granted for ECG Assessment of Heart Function, Further Expands HeartSciences' Patent Portfolio and IP Value2
28.05.HeartSciences ändert Unternehmenssatzung1
28.05.HeartSciences Inc. - 8-K, Current Report-
19.05.HeartSciences Inc. - 8-K, Current Report2
08.05.Heart Test Laboratories, Inc.: HeartSciences to Host Investor Webinar and Q&A on Wednesday May 14, 2025 - Featuring CEO Andrew Simpson6
07.05.Heart Test Laboratories, Inc.: HeartSciences Adds Prominent Key Advisors to its Scientific Advisory Board1
01.05.Heart Test Laboratories, Inc.: HeartSciences Announces Launch of MyoVista Insights Platform and Related Early Adopter Program1
21.03.HeartSciences Inc. - 8-K, Current Report1
13.03.Heart Test Laboratories reports Q3 results1
13.03.Heart Test Laboratories, Inc.: HeartSciences Provides Business Update and Reports Third Quarter Fiscal 2025 Financial Results152Southlake, TX, March 13, 2025 (GLOBE NEWSWIRE) -- HeartSciences Inc. (Nasdaq: HSCS; HSCSW) ("HeartSciences" or the "Company"), an artificial intelligence ("AI")-powered medical technology company...
► Artikel lesen
13.03.HeartSciences Inc. - 8-K, Current Report1
13.03.HeartSciences Inc. - 10-Q, Quarterly Report1
10.03.Heart Test Laboratories, Inc.: HeartSciences Inc. Engages Integrous Communications to Enhance Investor Communications2
21.01.HeartSciences Inc. - 8-K, Current Report-
16.12.24Heart Test Laboratories GAAP EPS of -$2.27 beats by $0.213
16.12.24Heart Test Laboratories, Inc.: HeartSciences Provides Business Update and Reports Second Quarter Fiscal 2025 Financial Results215Southlake, TX, Dec. 16, 2024 (GLOBE NEWSWIRE) -- HeartSciences Inc. (Nasdaq: HSCS; HSCSW) ("HeartSciences" or the "Company"), an artificial intelligence (AI)-powered medical technology company focused...
► Artikel lesen
16.12.24HeartSciences Inc. - 8-K, Current Report-
16.12.24HeartSciences Inc. - 10-Q, Quarterly Report-
Weiter >>
23 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1